AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue609,946532,091418,276124,384
Cost of Revenue239,119167,321117,39932,277
Gross Profit370,827364,770300,87792,107
Operating Expenses
Research Development19,06415,65213,98010,889
Selling General and Administrative307,619224,187156,03872,935
Non Recurring----
Others----
Total Operating Expenses565,802407,160287,417116,101
Operating Income or Loss44,144124,931130,8598,283
Income from Continuing Operations
Total Other Income/Expenses Net-414,238-115,876-91,015-25,625
Earnings Before Interest and Taxes44,144124,931130,8598,283
Interest Expense-68,382-73,153-53,251-14,697
Income Before Tax-370,0949,05539,844-17,342
Income Tax Expense-170,86611,5387,065-153,159
Minority Interest----
Net Income From Continuing Ops-199,228-2,48332,779135,817
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-199,228-2,48332,779135,817
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-199,228-2,48332,779135,817